1. Quaresma JA, Yoshikawa GT, Koyama RV, Dias GA, Fujihara S, Fuzii HT: HTLV-1, immune response and autoimmunity. Viruses 2016, 8:5.
2. Futsch N, Mahieux R, Dutartre H: HTLV-1, the other pathogenic yet neglected human retrovirus: from transmission to therapeutic treatment. Viruses 2018, 10:1.
3. Gonçalves DU, Proietti FA, Ribas JGR, Araújo MG, Pinheiro SR, Guedes AC, Carneiro-Proietti ABF: Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clinical microbiology reviews 2010, 23:577-589.
4. Mulherkar R, Karabudak A, Ginwala R, Huang X, Rowan A, Philip R, Murphy EL, Clements D, Ndhlovu LC, Khan ZK, Jain P: In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection. Vaccine 2018, 36:5046-5057.
5. Matsuoka M, Mesnard J-M: HTLV-1 bZIP factor: the key viral gene for pathogenesis. Retrovirology 2020, 17:1-8.
6. Koyanagi Y, Itoyama Y, Nakamura N, Takamatsu K, Kira J-I, Iwamasa T, Goto I, Yamamoto N: In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 1993, 196:25-33.
7. MACATONIA SE, Cruickshank J, RUDGE P, KNIGHT SC: Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS research and human retroviruses 1992, 8:1699-1706.
8. Takeda S, Maeda M, Morikawa S, Taniguchi Y, Yasunaga Ji, Nosaka K, Tanaka Y, Matsuoka M: Genetic and epigenetic inactivation of tax gene in adult T‐cell leukemia cells. International journal of cancer 2004, 109:559-567.
9. Jaworski E, Narayanan A, Van Duyne R, Shabbeer-Meyering S, Iordanskiy S, Saifuddin M, Das R, Afonso PV, Sampey GC, Chung M: Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein. Journal of Biological Chemistry 2014, 289:22284-22305.
10. Satou Y, Yasunaga J-i, Zhao T, Yoshida M, Miyazato P, Takai K, Shimizu K, Ohshima K, Green PL, Ohkura N: HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS pathogens 2011, 7.
11. Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J-i, Totoki Y, Chiba K, Sato-Otsubo A, Nagae G: Integrated molecular analysis of adult T cell leukemia/lymphoma. Nature genetics 2015, 47:1304.
12. Langfelder P, Horvath S: WGCNA: an R package for weighted correlation network analysis. BMC bioinformatics 2008, 9:559.
13. Tesson BM, Breitling R, Jansen RC: DiffCoEx: a simple and sensitive method to find differentially coexpressed gene modules. BMC bioinformatics 2010, 11:497.
14. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK: limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic acids research 2015, 43:e47-e47.
15. Zhang B, Horvath S: A general framework for weighted gene co-expression network analysis. Statistical applications in genetics and molecular biology 2005, 4.
16. Langfelder P, Horvath S: Fast R functions for robust correlations and hierarchical clustering. Journal of statistical software 2012, 46.
17. Raudvere U, Kolberg L, Kuzmin I, Arak T, Adler P, Peterson H, Vilo J: g: Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic acids research 2019, 47:W191-W198.
18. Ghobadi MZ, Mozhgani S-H, Erfani YJJoN: Identification of dysregulated pathways underlying HTLV-1-associated myelopathy/tropical spastic paraparesis through co-expression network analysis. 2021:1-11.
19. Bakhtiarizadeh MR, Mirzaei S, Norouzi M, Sheybani N, Vafaei Sadi MSJFig: Identification of gene modules and hub genes involved in mastitis development using a systems biology approach. 2020, 11:722.
20. Chen C, Meng Q, Xia Y, Ding C, Wang L, Dai R, Cheng L, Gunaratne P, Gibbs RA, Min SJStm: POU3F2 is a regulator of a gene coexpression network in brain tissue from patients with neuropsychiatric disorders. 2018, 10.
21. Nejmeddine M, Bangham CRJV: The HTLV-1 virological synapse. 2010, 2:1427-1447.
22. Mothes W, Sherer NM, Jin J, Zhong PJJov: Virus cell-to-cell transmission. 2010, 84:8360-8368.
23. Kim S-j, Nair AM, Fernandez S, Mathes L, Lairmore MDJTJoI: Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1. 2006, 176:5463-5470.
24. Martin JL, Maldonado JO, Mueller JD, Zhang W, Mansky LMJV: Molecular studies of HTLV-1 replication: An update. 2016, 8:31.
25. Fraedrich K, Müller B, Grassmann R: The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix. Retrovirology 2005, 2:54.
26. Jana A, Pahan KJNm: Sphingolipids in multiple sclerosis. 2010, 12:351-361.
27. Mozhgani S-H, Piran M, Zarei-Ghobadi M, Jafari M, Jazayeri S-M, Mokhtari-Azad T, Teymoori-Rad M, Valizadeh N, Farajifard H, Mirzaie MJR: An insight to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) pathogenesis; evidence from high-throughput data integration and meta-analysis. 2019, 16:1-11.
28. Mozhgani SH, Zarei‐Ghobadi M, Teymoori‐Rad M, Mokhtari‐Azad T, Mirzaie M, Sheikhi M, Jazayeri SM, Shahbahrami R, Ghourchian H, Jafari MJJocb: Human T‐lymphotropic virus 1 (HTLV‐1) pathogenesis: A systems virology study. 2018, 119:3968-3979.
29. Berneman ZJL: HTLV molecular biology and pathogenesis: Airlie Center, Warrenton, VA, USA, 17-19 March 2000. Leukemia 2001, 15:647-654.
30. Cliffe ARJMc: DNA damage meets neurotrophin signaling: a delicate balancing AKT to maintain virus latency. J Molecular cell 2019, 74:411-413.
31. Park H, Poo M-mJNRN: Neurotrophin regulation of neural circuit development and function. Nature Reviews Neuroscience 2013, 14:7-23.
32. Huang EJ, Reichardt LFJAron: Neurotrophins: roles in neuronal development and function. Annual review of neuroscience 2001, 24:677-736.
33. Nishida K, Hoshino M, Kawaguchi Y, Murakami FJJoBC: Ptf1a directly controls expression of immunoglobulin superfamily molecules Nephrin and Neph3 in the developing central nervous system. Journal of Biological Chemistry 2010, 285:373-380.
34. Mori T, Fukuda Y, Kuroda H, Matsumura T, Ota S, Sugimoto T, Nakamura Y, Inazawa JJB: Cloning and Characterization of a NovelRab-Family Gene, Rab36, within the Region at 22q11. 2 That Is Homozygously Deleted in Malignant Rhabdoid Tumors. Biochemical
biophysical research communications 1999, 254:594-600.
35. Zhu Y, Liang S, Pan H, Cheng Z, Rui XJJob: Inhibition of miR-1247 on cell proliferation and invasion in bladder cancer through its downstream target of RAB36. Journal of biosciences 2018, 43:365-373.
36. Vanzo RJ, Twede H, Ho KS, Prasad A, Martin MM, South ST, Wassman ERJEjomg: Clinical significance of copy number variants involving KANK1 in patients with neurodevelopmental disorders. European journal of medical genetics 2019, 62:15-20.
37. Cui Z, Shen Y, Chen KH, Mittal SK, Yang J-Y, Zhang GJSr: KANK1 inhibits cell growth by inducing apoptosis through regulating CXXC5 in human malignant peripheral nerve sheath tumors. Scientific reports 2017, 7:1-13.
38. Dor Y, Porat R, Keshet EJAJoP-CP: Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis. 2001, 280:C1367-C1374.
39. Caretta A, Mucignat-Caretta CJC: Protein kinase a in cancer. 2011, 3:913-926.
40. Fang Z, Zang W, Chen R, Ye B, Wang X, Yi S, Chen W, He F, Ye GJGMR: Gene expression profile and enrichment pathways in different stages of bladder cancer. 2013, 12:1479-1489.
41. Liu X, Wang J, Sun GJK, Research BP: Identification of key genes and pathways in renal cell carcinoma through expression profiling data. 2015, 40:288-297.
42. Soltani A, Hashemy SI, Avval FZ, Soleimani A, Rafatpanah H, Rezaee SA, Griffith R, Mashkani BJB, Pharmacotherapy: Molecular targeting for treatment of human T-lymphotropic virus type 1 infection. 2019, 109:770-778.